The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial

BACKGROUND: Patients with fibrotic interstitial lung disease (FILD) often experience gas exchange abnormalities and ventilatory limitations, resulting in reduced exercise capacity. High-flow nasal cannula (HFNC) oxygen therapy is a novel treatment, whose physiological beneficial effects have been de...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Atsushi, Ando, Masahiko, Kimura, Tomoki, Kataoka, Kensuke, Yokoyama, Toshiki, Shiroshita, Eiichi, Kondoh, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041255/
https://www.ncbi.nlm.nih.gov/pubmed/32093665
http://dx.doi.org/10.1186/s12890-020-1093-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041255/
https://www.ncbi.nlm.nih.gov/pubmed/32093665
http://dx.doi.org/10.1186/s12890-020-1093-2

Ejemplares similares